Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris Aims To Clear Up Investor ‘Disappointment’ After Breaking EBITDA Baseline
Company Also Reiterates $9bn Pre-Tax Proceeds Goal Via Divestments
Mar 10 2022
•
By
Dean Rudge
"Everything else" is competing with share buybacks • Source: Shutterstock
More from Strategy
More from Business